NYSE:WATLife Sciences
Waters (WAT) Valuation Check After Conference Updates And Renewed Goldman Sachs Support
Conference messages and analyst attention put Waters back in focus
Waters (WAT) has moved back onto investors' radar after its recent health care conference comments on growth priorities and BD Diagnostic Solutions integration, alongside a renewed supportive view from a major Wall Street bank.
See our latest analysis for Waters.
After a weak patch that left the 90 day share price return at a 20.35% decline and the 1 year total shareholder return at an 11.85% loss, recent gains around the TD...